A clinical oncology research team at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), in collaboration with the US National Cancer Institute (NCI), has developed an innovative big data platform, called the ...
Nov 19, 2025
0
0
Grape seed extract—a dietary supplement made from the seeds of wine grapes—has been investigated to see if it can help reduce blood cholesterol levels and high blood pressure. But can it also help slow down the growth ...
Oct 23, 2025
0
0
A surveillance study compared international cancer incidence trends of 13 cancer types in younger and older adults.
Oct 20, 2025
0
0
Elevated calcium levels in the blood—a complication of kidney cancers known as hypercalcemia—may be successfully treated with a class of medications called HIF-2α inhibitors developed by UT Southwestern Medical Center, ...
Oct 9, 2025
0
0
Cancer survival rates have improved over three decades as cancer mortality rates decline, according to new data published today by the Australian Institute of Health and Welfare (AIHW).
Oct 8, 2025
0
0
Researchers at London Health Sciences Center Research Institute (LHSCRI) have launched a Phase II clinical trial that aims to treat renal cell carcinoma (kidney cancer) by inserting microscopic beads filled with radiation ...
Oct 2, 2025
0
0
Modifiable risk factors such as obesity, smoking, lack of exercise, diabetes and hypertension are projected to be one of the main drivers of a steep rise in kidney cancer cases, doubling the amount worldwide over the next ...
Sep 26, 2025
0
0
The incidence of obesity-associated cancers in Puerto Rico rose significantly between 2000 and 2022, according to research presented at the 18th AACR Conference on the Science of Cancer Health Disparities, held September ...
Sep 19, 2025
0
0
The World Health Organization published updated editions of its Model List of Essential Medicines (EML) and Essential Medicines for Children (EMLc) to include new treatments for several cancers as well as for diabetes and ...
Sep 10, 2025
0
0
A simple urine test that can assess the risk of kidney cancer recurrence at an early stage could spare patients from frequent X-ray examinations and thus reduce the associated radiation, anxiety and costs.
Sep 1, 2025
0
0
Kidney cancer is a type of cancer that starts in the cells in the kidney.
The two most common types of kidney cancer are renal cell carcinoma (RCC) and urothelial cell carcinoma (UCC) of the renal pelvis. These names reflect the type of cell from which the cancer developed.
The different types of kidney cancer (such as RCC and UCC) develop in different ways, meaning that the diseases have different outlooks (or prognosis), and need to be staged and treated in different ways.
This text uses material from Wikipedia licensed under CC BY-SA
